Detailed answers about THE NEWCASTLE VOICE AND ENT CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was THE NEWCASTLE VOICE AND ENT CLINIC LIMITED founded?
THE NEWCASTLE VOICE AND ENT CLINIC LIMITED was officially incorporated on 23 February 2026 and is registered under company number 17048832. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE NEWCASTLE VOICE AND ENT CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THE NEWCASTLE VOICE AND ENT CLINIC LIMITED?
THE NEWCASTLE VOICE AND ENT CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE NEWCASTLE VOICE AND ENT CLINIC LIMITED do?
THE NEWCASTLE VOICE AND ENT CLINIC LIMITED operates in the following sector: 86210 - General medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is THE NEWCASTLE VOICE AND ENT CLINIC LIMITED's registered address?
The registered office address of THE NEWCASTLE VOICE AND ENT CLINIC LIMITED is C/O ECHO TAX LIMITED SPACES MANCHESTER, PETER HOUSE, OXFORD STREET, MANCHESTER, UNITED KINGDOM, M1 5AN. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE NEWCASTLE VOICE AND ENT CLINIC LIMITED financially stable?
Financial accounts for THE NEWCASTLE VOICE AND ENT CLINIC LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.